Wockhardt Ltd.

NSE: WOCKPHARMA · Healthcare

₹1,947.00-2.15%06 Nov 2026

Ask the data

Instant answers about Wockhardt Ltd. — computed from its filings, no language model

Market cap₹31,541 cr

Current price₹1,947.00

High / Low₹2,330 / ₹1,100

P/E76.9

P/B6.12

Book value₹318.4

ROE7.9%

ROCE9.1%

Debt / equity0.42

Dividend yield—

EPS (TTM)₹25.31

Face value₹5

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 9 periods

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	3,937	4,158	2,844	2,708	3,230	2,651	2,798	3,012	3,373
EBITDA	2	110	119	-63	298	101	39	393	652
Operating margin	0.0%	2.6%	4.2%	-2.3%	9.2%	3.8%	1.4%	13.0%	19.3%
Interest	255	265	276	249	299	302	305	254	213
Depreciation	150	166	224	246	247	251	223	217	227
Profit before tax	-641	-300	-342	-568	-411	-624	-420	-16	238
Tax	26	-84	-204	-272	-132	-3	52	41	39
Net profit	-608	-195	-69	686	-244	-559	-463	-47	213
EPS ₹	-55.01	-17.58	-6.25	61.95	-20.24	-38.79	-32.05	-3.02	13.12
Operating cash flow	—	—	—	—	413	153	219	-22	390
Capex	—	—	—	—	118	42	59	94	136
Dividend paid	—	—	—	—	0	0	0	0	0
Total assets	8,162	7,844	8,179	7,774	8,243	7,683	7,649	8,135	8,615
Equity	2,852	2,675	2,672	3,376	3,849	3,354	3,359	4,353	4,940

Quarterly performance

last 35 quarters · ₹ crore

showing latest 8 of 35 periods

	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	1,018	1,008	1,126	1,046	979	863	802	869	687	598	714	764	632	860	862	854	655	595	679	699	678	644	753	701	700	739	809	721	743	738	782	888	965	929	969
Operating profit	-6	4	67	-18	56	40	48	134	13	-72	17	58	-66	121	96	111	-33	-16	43	45	3	16	72	37	-103	91	110	128	64	72	178	177	225	192	173
Operating margin	-0.6%	0.4%	6.0%	-1.7%	5.7%	4.6%	5.9%	15.4%	2.0%	-12.0%	2.3%	7.6%	-10.5%	14.1%	11.1%	13.1%	-5.0%	-2.7%	6.3%	6.4%	0.4%	2.5%	9.6%	5.3%	-14.7%	12.3%	13.6%	17.8%	8.6%	9.8%	22.8%	19.9%	23.3%	20.7%	17.9%
Other income	-8	7	6	2	5	8	-0	17	14	8	16	101	8	2	5	2	14	57	57	2	32	14	24	8	54	30	9	8	15	20	21	25	45	31	11
Interest	65	73	65	64	64	71	65	79	61	74	61	60	55	64	69	80	86	73	70	83	76	79	76	77	73	73	73	60	48	48	55	60	50	52	56
Depreciation	38	39	40	41	45	55	53	56	61	56	57	68	65	64	61	62	59	64	65	66	56	55	55	55	58	54	55	55	53	56	53	65	53	55	55
Profit before tax	-118	-100	-32	-121	-48	-78	-71	16	-95	-336	-85	31	-178	-6	-29	-29	-347	-96	-230	-105	-193	-118	-35	-87	-180	-6	-9	21	-22	-109	91	67	189	116	73
Tax	35	-5	-1	-44	-34	-41	24	-3	-144	-111	-88	-1	-71	1	-66	-30	-36	-21	-23	-3	44	18	38	-1	-3	10	7	1	23	-1	9	6	25	9	0
Net profit	-155	-62	0	0	-14	-37	-82	10	48	760	4	15	-93	-13	34	-7	-258	-67	-189	-96	-208	-134	-77	-83	-169	-14	-22	14	-25	-90	78	59	166	106	79
EPS ₹	-13.97	-7.79	-2.06	-6.42	-1.31	-4.06	-7.42	0.87	4.36	68.64	0.32	1.38	-8.38	-1.15	3.03	-0.61	-21.20	-4.64	-13.15	-6.62	-14.37	-9.28	-5.37	-5.75	-11.64	-0.95	-1.47	0.91	-1.57	-5.53	4.81	3.61	10.23	6.55	4.85
Revenue YoY	—	—	—	—	-3.8%	-14.3%	-28.7%	-16.9%	-29.8%	-30.7%	-11.0%	-12.1%	-8.0%	43.7%	20.7%	11.8%	3.6%	-30.8%	-21.2%	-18.1%	3.5%	8.2%	10.9%	0.3%	3.2%	14.8%	7.4%	2.9%	6.1%	-0.1%	-3.3%	23.2%	29.9%	25.9%	23.9%
Profit YoY	—	—	—	—	—	—	—	—	—	—	—	58.3%	-292.2%	-101.7%	844.5%	-144.5%	—	—	-663.7%	—	—	—	—	—	—	—	—	—	—	—	—	321.4%	—	—	1.3%

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Wockhardt Ltd. reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	1,531	1,528	1,755	2,560	2,556	1,805	1,887	2,225	2,298
Operating profit	370	375	393	826	589	66	25	135	142
Operating margin	24.2%	24.5%	22.4%	32.2%	23.1%	3.7%	1.3%	6.1%	6.2%
Other income	38	21	17	20	48	279	448	50	252
Interest	210	180	190	161	107	34	19	80	169
Depreciation	51	57	62	66	81	96	103	102	106
Profit before tax	-495	-774	-132	384	708	215	350	3	119
Tax	-115	0	0	200	85	16	19	-30	-18
Net profit	-380	-774	-132	184	623	199	332	33	137

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	345	295	330	387	417	374	354	367	383	395	382	400	475	457	423	551	638	652	719	607	605	555	789	501	460	423	420	485	467	443	491	515	568	630	511	613	598	545	541	440	589	535
Operating profit	82	50	68	84	100	99	87	77	104	86	108	89	104	101	99	149	181	191	305	133	129	101	227	64	16	-3	-11	31	19	-21	-5	2	3	120	10	53	22	16	50	-78	53	19
Operating margin	23.9%	17.0%	20.6%	21.6%	24.0%	26.6%	24.7%	21.1%	27.2%	21.6%	28.2%	22.3%	21.9%	22.0%	23.3%	27.0%	28.4%	29.3%	42.3%	21.9%	21.2%	18.2%	28.8%	12.7%	3.5%	-0.6%	-2.6%	6.5%	4.0%	-4.7%	-1.0%	0.4%	0.6%	19.0%	1.9%	8.7%	3.7%	3.0%	9.3%	-17.6%	9.0%	3.5%
Other income	2	2	2	3	2	17	16	7	4	4	6	4	4	4	5	5	2	9	4	6	17	-10	35	-20	164	63	72	2	431	7	8	8	5	18	18	18	189	27	18	22	12	12
Interest	0	2	22	50	10	72	78	58	34	29	59	36	41	40	73	39	36	51	34	33	5	19	50	5	5	17	6	5	5	3	6	10	18	21	31	44	42	42	41	43	44	41
Depreciation	9	9	10	10	12	14	15	14	14	15	14	15	15	15	16	23	14	14	15	16	20	22	22	22	28	23	22	25	27	26	25	25	25	26	26	26	27	28	25	27	26	27
Profit before tax	76	41	38	26	24	-516	-30	-261	-59	-160	-294	-163	-68	67	32	91	60	135	99	83	388	46	190	17	146	19	32	4	418	-43	-28	-25	-34	92	-30	2	142	-26	2	-124	-4	-38
Tax	17	8	38	3	11	-130	1	0	0	0	0	0	0	0	0	8	6	18	168	9	43	-4	37	1	12	-6	10	-2	52	-18	-14	-0	5	2	-36	-15	-5	-7	8	-23	-29	-10
Net profit	59	34	1	23	13	-386	-30	-261	-59	-160	-294	-163	-68	67	32	83	54	116	-69	74	345	51	153	16	135	26	22	5	366	-25	-14	-25	-39	90	7	16	146	-19	-6	-102	25	-28
EPS ₹	5.38	3.10	0.07	2.13	1.22	-35.30	-2.78	-23.81	-5.40	-14.62	-26.89	-14.91	-6.20	6.09	2.95	7.55	4.91	10.61	-6.27	6.76	31.55	4.62	13.93	1.45	12.27	2.35	2.04	0.49	33.26	-2.31	-1.28	-2.27	-3.54	8.16	0.61	1.48	13.22	-1.80	-0.54	-9.19	2.29	-2.49
Revenue YoY	—	—	—	—	20.9%	26.5%	7.2%	-5.3%	-8.0%	5.8%	8.0%	9.0%	23.9%	15.5%	10.8%	37.8%	34.4%	42.7%	69.9%	10.3%	-5.3%	-14.9%	9.6%	-17.5%	-23.9%	-23.7%	-46.7%	-3.2%	1.5%	4.7%	16.7%	6.0%	21.7%	42.2%	4.2%	19.2%	5.3%	-13.5%	5.7%	-28.3%	-1.6%	-1.9%
Profit YoY	—	—	—	—	-77.2%	-1239.6%	-4448.6%	-1216.0%	-540.0%	—	—	—	—	—	—	—	—	74.2%	-312.8%	-10.4%	541.8%	-56.4%	—	-78.6%	-61.0%	-49.0%	-85.4%	-66.3%	171.9%	-198.4%	-163.0%	-566.9%	-110.7%	—	—	—	—	-121.6%	-187.9%	-722.0%	-82.7%	—

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 32 periods

	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	-7.6%	-2.9%	-1.9%	-5.0%	-4.6%	-2.3%	27.5%	30.7%	31.0%	20.3%	-2.6%	-1.7%	-2.3%	-6.3%	-7.7%	-14.9%	-17.5%	-16.7%	-18.7%	-16.5%	-16.1%	-13.8%	-10.2%	-8.5%	-5.6%	-1.1%	-2.8%	-0.5%	0.5%	4.3%	8.3%	7.9%
ROCE	-1.9%	-0.7%	-0.3%	-1.1%	1.9%	1.0%	-4.3%	-4.7%	-4.8%	-5.6%	0.0%	1.1%	0.5%	-2.0%	-3.4%	-7.3%	-8.7%	-6.1%	-6.4%	-2.7%	-2.4%	-2.1%	-0.2%	0.3%	1.9%	3.8%	1.8%	2.8%	3.5%	6.4%	9.6%	9.1%
Net margin	-5.2%	-1.8%	-1.3%	-3.6%	-3.5%	-1.9%	24.9%	28.6%	29.9%	25.3%	-2.9%	-1.8%	-2.5%	-7.6%	-10.1%	-18.7%	-23.2%	-21.1%	-23.2%	-18.6%	-18.1%	-16.5%	-11.9%	-9.8%	-6.4%	-1.6%	-4.1%	-0.8%	0.7%	6.3%	11.5%	10.9%
EBITDA margin	1.1%	2.6%	3.6%	3.4%	7.9%	7.3%	4.2%	3.2%	0.6%	-2.3%	4.4%	6.7%	8.2%	9.1%	5.3%	3.8%	1.5%	2.8%	4.0%	4.9%	4.6%	0.8%	3.4%	4.6%	7.6%	13.0%	12.4%	14.8%	15.6%	19.3%	21.7%	20.4%
Debt / equity	0.92	0.92	0.92	0.92	0.92	0.80	0.80	0.80	0.80	0.69	0.69	0.69	0.69	0.48	0.48	0.53	0.53	0.56	0.56	0.64	0.64	0.63	0.63	0.63	0.63	0.43	0.43	0.51	0.51	0.43	0.43	0.42
Interest coverage	-0.39	-0.13	-0.06	-0.21	0.35	0.18	-0.74	-0.82	-0.90	-1.28	0.01	0.26	0.10	-0.37	-0.63	-1.27	-1.49	-1.07	-1.10	-0.44	-0.41	-0.38	-0.03	0.05	0.38	0.94	0.48	0.91	1.13	2.12	3.13	3.04
Asset turnover	0.51	0.53	0.51	0.47	0.45	0.39	0.36	0.35	0.34	0.35	0.38	0.40	0.41	0.39	0.36	0.36	0.34	0.35	0.35	0.37	0.37	0.37	0.38	0.39	0.39	0.37	0.37	0.35	0.37	0.39	0.41	0.42

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 17 periods

	MAR '14‡	MAR '15‡	MAR '17‡	MAR '18‡	MAR '19‡	MAR '20‡	MAR '21‡	MAR '22‡	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	353	354	55	55	55	55	55	72	72	72	72	77	77	81	81	81	81
Other equity / reserves	3,092	3,218	3,281	2,797	2,619	2,616	3,321	3,777	3,422	3,282	3,053	3,282	3,318	4,272	4,486	4,859	5,077
Total equity	3,445	3,571	3,337	2,852	2,675	2,672	3,376	3,849	3,494	3,354	3,125	3,359	3,395	4,353	4,567	4,940	5,158
Borrowings	1,312	1,533	3,853	2,610	2,453	2,145	2,332	1,862	1,856	1,887	2,003	2,112	2,154	1,859	2,323	2,125	2,150
Current liabilities	1,743	1,773	1,979	2,692	2,864	3,497	3,121	3,207	3,246	3,435	2,685	2,791	2,380	2,042	1,736	1,622	1,785
Non-current liabilities	1,161	1,307	3,324	2,272	1,976	1,624	894	834	751	586	1,303	1,196	1,495	1,436	1,921	1,712	1,617
Total assets	6,622	6,939	9,022	8,162	7,844	8,179	7,774	8,243	7,834	7,683	7,420	7,649	7,588	8,135	8,533	8,615	8,902
Property, plant & equipment	1,339	1,315	1,942	1,948	2,124	1,857	1,719	1,908	2,235	2,022	1,929	1,875	1,806	1,718	1,673	1,618	1,601
Capital work-in-progress	708	1,007	971	1,039	900	836	603	389	395	414	419	434	481	513	583	671	676
Investments	577	341	563	214	0	0	0	0	0	0	0	0	48	422	696	412	117
Inventories	993	1,021	1,108	856	819	690	799	769	748	658	635	640	657	725	866	887	973
Receivables	481	741	1,034	962	1,274	1,243	918	918	816	797	714	618	695	661	536	588	632
Cash & equivalents	1,126	1,235	964	897	397	219	232	370	187	90	54	505	143	112	177	217	330

Cash flow

annual · ₹ crore · line = free cash flow

showing latest 5 of 11 periods

	FY16‡	FY17‡	FY18‡	FY19‡	FY20‡	FY21‡	FY22	FY23	FY24	FY25	FY26
Cash from operations	-42	-269	68	183	649	-287	413	153	219	-22	390
Cash from investing	-106	-687	630	95	-156	1,470	-201	-125	-137	-783	-241
Cash from financing	193	1,254	-769	-776	-680	-1,171	-71	-315	334	409	-54
Capex	—	411	307	275	172	166	118	42	59	94	136
Free cash flow	—	-680	-239	-92	477	-453	295	111	160	-116	254
Dividends paid	21	138	0	0	0	1	0	0	0	0	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,601 cr18%

CWIP

₹676 cr8%

Investments

₹117 cr1%

Inventories

₹973 cr11%

Receivables

₹632 cr7%

Cash & equivalents

₹330 cr4%

Other assets

₹4,573 cr51%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Wockhardt Ltd.	31,541	1,947.00	76.9	6.12	7.9%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-9.5%

6 months+18.9%

1 year+49.0%

3Y CAGR+102.7%

5Y CAGR+35.5%

10Y CAGR+10.0%

50-day avg₹2,027.75

200-day avg₹1,716.69

RSI (14)49

Compare Wockhardt Ltd. with

Dr. Lal Path Labs vs Wockhardt Piramal Pharma vs Wockhardt Wockhardt vs Acutaas Chemicals Wockhardt vs Krishna Institute of Medical Sciences Wockhardt vs Rubicon Research

FAQs

What is the share price of Wockhardt Ltd.?

Wockhardt Ltd. (WOCKPHARMA) closed at ₹1,947.00 on NSE on 06 Nov 2026.

What is the market cap of Wockhardt Ltd.?

₹31,541 crore at the latest close.

What is the P/E ratio of Wockhardt Ltd.?

76.9, on trailing-twelve-month earnings from its filings.

How fast is Wockhardt Ltd. growing?

Wockhardt Ltd.: revenue has compounded at 8.4% a year over three years. Latest-quarter revenue is up 23.9% year on year, profit up 1.3%.

How profitable is Wockhardt Ltd.?

On a trailing-twelve-month basis return on equity is 7.9%, return on capital employed 9.1%, operating margin 20.4%, net margin 10.9%.

How much debt does Wockhardt Ltd. have?

Wockhardt Ltd. is lightly geared: debt to equity is 0.42 with borrowings of ₹2,150 cr against cash of ₹330 cr (balance sheet of 2026-09-30). Operating profit covers interest 3.0 times.

Financials parsed from Wockhardt Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Mar '14. * = derived (full year or half year minus earlier quarters). ‡ = balance sheet / cash flow read from the company's published annual report (same basis), for years before the NSE filings carry them; each one checked to add up. Information only, not investment advice.